CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 46 filers reported holding CIDARA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,439,000 | +28.6% | 426,851 | +41.6% | 0.00% | 0.0% |
| Q3 2016 | $3,451,000 | +21.6% | 301,434 | +9.5% | 0.00% | 0.0% |
| Q2 2016 | $2,838,000 | +81.5% | 275,247 | +123.6% | 0.00% | – |
| Q1 2016 | $1,564,000 | -30.0% | 123,125 | -5.5% | 0.00% | -100.0% |
| Q4 2015 | $2,235,000 | +36.1% | 130,256 | +0.9% | 0.00% | – |
| Q3 2015 | $1,642,000 | -8.6% | 129,126 | +0.8% | 0.00% | – |
| Q2 2015 | $1,797,000 | – | 128,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |